Koers Sunshine Heart Inc Nasdaq
Aandelen
US86782U1060
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 8,98 mln. 8,26 mln. | Omzet 2025 * | 10,32 mln. 9,5 mln. | Marktkapitalisatie | 4,5 mln. 4,14 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -9,2 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,28 mln. | EV/omzet 2024 * | 0,5 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,44 x |
K/w-verhouding 2024 * |
-0,26
x | K/w-verhouding 2025 * |
-0,92
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,21% |
Recentste transcriptie over Sunshine Heart Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07-05-19 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01-01-13 |
John Erb
CHM | Chairman | 75 | 01-09-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01-09-12 |
Director/Board Member | 61 | 01/11 | |
Gregory Waller
BRD | Director/Board Member | 74 | 03-08-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,56% | 223 mld. | |
+11,46% | 195 mld. | |
+18,52% | 144 mld. | |
+29,82% | 111 mld. | |
+2,32% | 65,19 mld. | |
+13,88% | 53,02 mld. | |
+2,68% | 50,28 mld. | |
+6,88% | 44,15 mld. | |
+1,84% | 36,45 mld. |